glp-1 obesity drug news today september 15 2025 The first of three of our Appetite for Answers series! Understanding GLP-1s Beyond the Headlines medications are currently a major topic of discussion, and unfortunately, misinformation is spreading—not only among the The FDA approved a new
Description
2025;S01616420(25):001320
And even the smallest shift in how people react to such drugs (whether thats through drinking less alcohol, needing more hydration, or muting food noise) could have a huge impact on what people want from food and beverages
El K, Douros JD, Willard FS, et al
p = 0.04)
Testing of several negative outcome controls yielded null results consistent with a priori expectations (supplementary table S16)
